Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

InspireMD (NSPR) Accumulated Depreciation & Amortization (2016 - 2025)

InspireMD filings provide 14 years of Accumulated Depreciation & Amortization readings, the most recent being $476.0 million for Q4 2025.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 70.0% to $476.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $476.0 million, a 70.0% increase, with the full-year FY2025 number at $476.0 million, up 70.0% from a year prior.
  • Accumulated Depreciation & Amortization hit $476.0 million in Q4 2025 for InspireMD, up from $280.0 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $476.0 million in Q4 2025 to a low of $1.7 million in Q4 2021.
  • Median Accumulated Depreciation & Amortization over the past 5 years was $232.0 million (2023), compared with a mean of $235.5 million.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: skyrocketed 10779.63% in 2022 and later increased 20.69% in 2024.
  • InspireMD's Accumulated Depreciation & Amortization stood at $1.7 million in 2021, then surged by 10779.63% to $188.0 million in 2022, then increased by 23.4% to $232.0 million in 2023, then grew by 20.69% to $280.0 million in 2024, then skyrocketed by 70.0% to $476.0 million in 2025.
  • The last three reported values for Accumulated Depreciation & Amortization were $476.0 million (Q4 2025), $280.0 million (Q4 2024), and $232.0 million (Q4 2023) per Business Quant data.